Cargando…
Novel Insights on the Role of Epigenetics in Androgen Receptor’s Expression in Prostate Cancer
The androgens/androgen receptor (AR) axis is the main therapeutic target in prostate cancer (PCa). However, while initially responsive, a subset of tumors loses AR expression through mechanisms putatively associated with epigenetic modifications. In this study, we assessed the link between the prese...
Autores principales: | Camilo, Vânia, Pacheco, Mariana Brütt, Moreira-Silva, Filipa, Outeiro-Pinho, Gonçalo, Gaspar, Vítor M., Mano, João F., Marques, C. Joana, Henrique, Rui, Jerónimo, Carmen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605369/ https://www.ncbi.nlm.nih.gov/pubmed/37892208 http://dx.doi.org/10.3390/biom13101526 |
Ejemplares similares
-
Repurposing Old Drugs into New Epigenetic Inhibitors: Promising Candidates for Cancer Treatment?
por: Moreira-Silva, Filipa, et al.
Publicado: (2020) -
Hydralazine and Panobinostat Attenuate Malignant Properties of Prostate Cancer Cell Lines
por: Pacheco, Mariana Brütt, et al.
Publicado: (2021) -
Hydralazine and Enzalutamide: Synergistic Partners against Prostate Cancer
por: Lopes, Nair, et al.
Publicado: (2021) -
Renal Cell Tumors: Uncovering the Biomarker Potential of ncRNAs
por: Outeiro-Pinho, Gonçalo, et al.
Publicado: (2020) -
From Therapy Resistance to Targeted Therapies in Prostate Cancer
por: Moreira-Silva, Filipa, et al.
Publicado: (2022)